Cargando…

Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?

Detalles Bibliográficos
Autores principales:	Cottin, Vincent, Brown, Kevin K., Flaherty, Kevin R., Wells, Athol U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746830/ https://www.ncbi.nlm.nih.gov/pubmed/35868029 http://dx.doi.org/10.1164/rccm.202206-1143LE

Ejemplares similares

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response
por: Cottin, Vincent, et al.
Publicado: (2011)

Progressive pulmonary fibrosis: an expert group consensus statement
por: Rajan, Sujeet K., et al.
Publicado: (2023)

Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics
por: Kolb, Martin, et al.
Publicado: (2023)

Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions
por: Khor, Yet H., et al.
Publicado: (2022)

Analyses of the Efficacy and Safety of Antifibrotic Therapies in Non-IPF Pulmonary Fibrosis, Progressing Despite Management
por: Wells, Athol U.
Publicado: (2022)

Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity
por: Richeldi, Luca, et al.
Publicado: (2019)

Before Freezing Out Cryobiopsy, We Need to Thaw Out Flaws in the Diagnosis of Interstitial Lung Disease
por: Maldonado, Fabien, et al.
Publicado: (2019)

What we should focus on and reach out to
por: Nishimura, T.
Publicado: (2023)

Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression
por: Parra-Medina, Rafael, et al.
Publicado: (2021)

The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF) - practical implications
por: Wells, Athol U
Publicado: (2013)

Ultrasound in COVID-19: a timeline of ultrasound findings in relation to CT
por: Fiala, M.J.
Publicado: (2020)

Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse
por: Johannson, Kerri A., et al.
Publicado: (2022)

Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022)

Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2017)

Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial
por: Flaherty, Kevin R., et al.
Publicado: (2022)

Rescheduling/scheduling of endoscopic procedures during “Phase-Two: which precautions should be taken?” Experience and results of a single Italian Endoscopic Unit
por: Bisogni, Damiano, et al.
Publicado: (2021)

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020)

Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
por: Rose, Jonathan A., et al.
Publicado: (2022)

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
por: George, Peter M, et al.
Publicado: (2020)

How Milk Should Be Taken
por: Duckworth, Dyce
Publicado: (1881)

Criteria for Progressive Pulmonary Fibrosis: Getting the Horse Ready for the Cart
por: Cottin, Vincent
Publicado: (2022)

Should We Avoid Saline in Sepsis? It’s Probably Too Early to Definitively Conclude
por: Gueret, Gildas, et al.
Publicado: (2020)

Smoking and Pulmonary Fibrosis: Novel Insights
por: Samara, Katerina D., et al.
Publicado: (2011)

Functional Criteria to Define Progressive Pulmonary Fibrosis: Searching for the Holy Grail
por: Noboa-Sevilla, María, et al.
Publicado: (2022)

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
por: Flaherty, Kevin R, et al.
Publicado: (2017)

Should valproate be taken during pregnancy?
por: Eadie, Mervyn J, et al.
Publicado: (2005)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Funke-Chambour, Manuela, et al.
Publicado: (2022)

Definition of Chronic Obstructive Pulmonary Disease: Occupational Environmental Contribution
por: Harber, Philip
Publicado: (2022)

Reply to Moran-Mendoza: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
por: Raghu, Ganesh, et al.
Publicado: (2022)

Pulmonary fibrosis associated with psychotropic drug therapy: a case report
por: Thornton, Clare, et al.
Publicado: (2009)

The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020)

Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis
por: Moore, Bethany B., et al.
Publicado: (2014)

Chronic Obstructive Pulmonary Disease Definition: Is It Time to Incorporate the Concept of Failure of Lung Regeneration?
por: Confalonieri, Marco, et al.
Publicado: (2022)

Online timeline
por: Carlson, David
Publicado: (2005)

Decade timeline
Publicado: (2009)

Timeline: Vaccines
por: Rappuoli, Rino
Publicado: (2020)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Novel Insight into Pulmonary Fibrosis and Long COVID
por: Kamp, Jan C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iro3dh6v5010qr8q0bemtfvlcr